ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunogenicity"

  • 2018 American Transplant Congress

    Not All HLA Mismatches Are Equal: Determining the Relative De Novo DSA Induction Capacity of HLA Mismatches

    V. Jucaud,1 L. Rebellato,2 K. Briley,2 A. Maldonado,3 C. Haisch,2 P. Bolin,2 S. Kendrick,4 H. Jones,4 K. McLawhorn,4 D. Leeser,2 M. Everly.1

    1Terasaki Research Institute, Los Angeles, CA; 2East Carolina University, Greenville, NC; 3Vidant Medical Center, Greenville, NC; 4Eastern Nephrology Associates, Greenville, NC.

    We studied the immunogenicity, defined as the development of de novo DSA (dnDSA), of HLA-A, -B, -DR and -DQ MM (serological) in a cohort of…
  • 2018 American Transplant Congress

    Anti-IdeS Antibodies in IVIg and Its Effect on IdeS Activity

    A. Runström,1 S. Järnum,1 S. Jordan,2 L. Winstedt,1 C. Kjellman.1

    1Hansa Medical AB, Lund, Sweden; 2Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles.

    ObjectiveEvaluate how and why intravenous gamma globulin (IVIg) affects IdeS-cleavage of IgG.IntroductionIgG degrading enzyme of Streptococcus pyogenes (IdeS) cleaves human IgG in two steps, first…
  • 2018 American Transplant Congress

    The Relative Immunogenicity of HLA Mismatches in Adult Liver Transplant Recipients

    V. Jucaud,1 A. Shaked,2 M. DesMarais,3 P. Sayre,3 M. Everly.1

    1Terasaki Research Institute, Los Angeles, CA; 2University of Pennsylvania, Philadelphia, PA; 3Immune Tolerance Network, Seattle, WA.

    Determining the immunogenicity of HLA mismatches (MM) may help preventing the appearance of de novo DSA (dnDSA) and avoiding antibody-mediated injuries.We studied the development of…
  • 2018 American Transplant Congress

    Ex-Vivo Pretreatment of Islets with Mitomycin-C Have a Potential to Induce Specific Immune Response for Peripheral Tolerance

    N. Sato, A. Kenjo, T. Kimura, R. Okada, T. Ishigame, Y. Kofunato, J. Watanabe, M. Muto, S. Suzushino, T. Shimura, S. Marubashi.

    Hepato-Biliary-Pancreatic and Transplant Sugery, Fukushima Medical University, Fukushima, Japan.

    Background.Our previous study demonstrated that ex-vivo Mitomycin-C(MMC) pretreatment of islets reduced immunogenicity, enhancing graft survival without immunosuppression(IS). However, it is still unclear whether donor specific…
  • 2018 American Transplant Congress

    Impact of Immunogenicity on Kidney Allograft Survival in Patients Treated with Induction Therapy

    D. Bekbolsynov, B. Mierzejewska, M. Rees, J. Ortiz, O. Ekwenna, S. Stepkowski.

    University of Toledo, Toledo.

    Background. The induction therapy is currently used in the majority of kidney transplant recipients, regardless of their level of donor/recipient compatibility. We examined whether lower…
  • 2018 American Transplant Congress

    Immunogenic HLA Mismatches and Evidence That Belatacept May Be the First Therapy Able to Prevent DQ De Novo DSA: An Analysis of the BENEFIT and BENEFIT-EXT Trial Cohorts

    M. Everly,1 V. Jucaud,1 M. Roberts,2 H. Gebel,3 R. Bray.3

    1Terasaki Research Institute, Los Angeles, CA; 2Immunology Biomarker Group, Bristol-Myers Squibb, Princeton, NJ; 3Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.

    The use of belatacept over cyclosporine is associated with lower rates of DSA development in adult kidney transplantation. However, the effect of belatacept on the…
  • 2018 American Transplant Congress

    Simultaneous Persistence and Development of Donor and Recipient Tissue Resident Memory T Cells in Lung Transplantation

    M. Snyder,1 T. Connors,2 C. Marboe,3 L. Benvenuto,1 L. Shah,1 H. Robbins,1 J. Hook,1 F. D'Ovidio,4 M. Bacchetta,4 J. Sonnett,4 S. Arcasoy,1 D. Farber.4,5

    1Medicine, Columbia University Medical Center, New York, NY; 2Pediatrics, Columbia University Medical Center, New York, NY; 3Pathology, Columbia University Medical Center, New York, NY; 4Surgery, Columbia University Medical Center, New York, NY; 5Microbiology & Immunology, Columbia University Medical Center, New York, NY.

    Introduction: The predominant T cell population in the lung comprises non-circulating tissue-resident memory T cells (TRM); however, the fate of these cells in transplanted lung…
  • 2018 American Transplant Congress

    Graft Perfusion with Alvespimycin, an HSP90 Inhibitor, Suppresses Acute Allograft Rejection and Prolongs Graft Survival in Murine Heart Transplantation

    T. Tanaka, T. Maehana, N. Masumori.

    Department of Urology, Sapporo Medical University, Sapporo, Japan.

    Purpose: We have previously demonstrated that administration of a heat shock protein 90 (HSP90) inhibitor to recipients prolonged the allograft survival in murine skin and…
  • 2017 American Transplant Congress

    In Vitro Optimisation of the Immunotherapeutic Effects of Umbilical Cord Derived MSC.

    S. de Witte,1 A. Merino,1 M. Franquesa,1 T. Strini,1 J. van Zoggel,1 S. Korevaar,1 F. Luk,1 M. Gargesha,4 D. Roy,4 S. Elliman,2 P. Newsome,3 C. Baan,1 M. Hoogduijn.1

    1Department of Internal Medicine, ErasmusMC, Rotterdam, Netherlands; 2Orbsen Therapeutics Ltd., Galway, Ireland; 3Department of NIHR Liver Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom; 4BioInVision Inc., Mayfield Village

    Mesenchymal stromal cells (MSC) possess immunomodulatory properties and are low immunogenic, which are both important for their development into an effective cellular immunotherapy after organ…
  • 2017 American Transplant Congress

    Soluble Human Leukocyte Antigen-G Levels and Prolonged Allograft Survival: A Demographic Analysis.

    C. Callaway,1 A. Ajith,2 V. Portik-Dobos,2 P. Best,3 C. Zayas,3 R. Kapoor,3 A. Horuzsko,2 L. Mulloy.3

    1Medical College of Georgia, Augusta University, Augusta, GA; 2Georgia Cancer Center, Augusta University, Augusta, GA; 3Section of Nephrology, Department of Medicine, Augusta University, Augusta, GA

    Human leukocyte antigen-G (HLA-G) is a tolerogenic protein shown to contribute to allograft survival. Dimerized, soluble HLA-G (sHLA-Gd) has been shown to significantly prolong allograft…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 13
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences